Why the study?
It was unclear whether ventricular longitudinal strain can serve as a prognostication tool in patients with COVID-19.
Does lower ventricular longitudinal strain predict poor outcome in patients with COVID-19?
Does lower ventricular longitudinal strain predict poor outcome in patients with COVID-19?
Lower left and right ventricular longitudinal strains measured by echocardiography are independently associated with poor clinical outcomes, including mortality, in patients with COVID-19.
Answers are grounded in this paper and cite their sources.
Lower ventricular strain associated with poor COVID-19 outcomes; supports prognostication use but leaves open prospective validation needs.
Background This systematic review and meta-analysis aimed to assess whether ventricular longitudinal strain can be used as a prognostication tool in patients with coronavirus disease 2019 (COVID-19). Methods Systematic literature searches of PubMed, Embase, and EuropePMC databases were performed on 16 November 2020. Left ventricular global longitudinal strain (LV-GLS) refers to LV contraction measurement using the speckle tracking-based method refers to the mean of strain values of the RV free wall (three segments) measured using echocardiography. The main outcome was poor outcome, defined as a composite of mortality and severe COVID-19. Results Seven studies comprising of 612 patients were included in meta-analysis. Six studies have mortality as their outcome, and 1 study has severity as their outcome. Patients with poor outcome have lower LV-GLS (SMD 1.15 (0.57, 1.72), p < 0.001; I 2 70.4%). Each 1% decrease in LV-GLS was associated with 1.4x increased risk of poor outcome (OR 1.37 (1.12, 1.67), p = 0.002; I 2 48.8%). Patients with poor outcome have lower RV-LS (SMD 1.18 (0.91, 1.45), p < 0.001; I 2 0%). Each 1% decrease in RV-LS was associated with 1.3x increased risk of poor outcome (OR 1.25 (1.15, 1.35), p < 0.001; I 2 11.8%). Subgroup analysis showed that for every 1% decrease in LV-GLS and RV-LS is increased mortality with OR of 1.30 (1.12, 1.50) and OR of 1.24 (1.14, 1.35), respectively. Conclusion This study shows that lower LV-GLS and RV-LS measurements were associated with poor outcome in patients with COVID-19. Trial registration PROSPERO CRD42020221144
No takes yet. Share an insight, caveat, or question.
Wibowo et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: